• Ownership

Lawrence Klein - Insider Trading & Ownership

Entity
Individual
Location
C/O Crispr Therapeutics Ag, 610 Main Street 7 Th Floor, Cambridge, MA
Summary
The estimated net worth of Lawrence Klein is at least $4.23M dollars as of January 24, 2025. Lawrence Klein is the Chief Executive Officer, Director of Oruka Therapeutics, Inc. and owns shares of Oruka Therapeutics, Inc. (ORKA) stock worth about $2.54M. Lawrence Klein is the CBO & COO of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $1.67M. Lawrence Klein is the Director of Jasper Therapeutics, Inc. and owns shares of Jasper Therapeutics, Inc. (JSPR) stock worth about $15.9K.
All Insider Reports
All Insider Reports

Ownership of Lawrence Klein

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ORKA Oruka Therapeutics, Inc. Chief Executive Officer, Director $2.54M Jan 22, 2025
CRSP CRISPR Therapeutics AG Cbo & Coo $1.67M Aug 16, 2022
JSPR, JSPRW Jasper Therapeutics, Inc. Director $15.9K Jun 7, 2023
DYN Dyne Therapeutics, Inc. Director Jul 5, 2022

Insider Transactions Reported by Lawrence Klein:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.